NR2F2 and colorectal carcinoma: Finally, Shin et al. have proposed that increased expression of COUP-TFII in colorectal carcinomas is correlated to good clinicopathologic features and recommend the use of COUP-TFII as a biomarker for good prognosis in colorectal cancer [65].